Editorial: The role of sphingolipid metabolism in endocrine diseases

Front Endocrinol (Lausanne). 2024 Oct 30:15:1506971. doi: 10.3389/fendo.2024.1506971. eCollection 2024.

Authors

Cao Li¹, Guangbi Li²

Affiliations

¹ Department of Pharmacy, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
² Department of Pharmacology and Toxicology, School of Medicine, Virginia Commonwealth University, Richmond, VA, United States.

No abstract available

Keywords: diabetes; glucose homeostasis; lipidomics; obesity; sphingolipid.

Publication types

Editorial